C ontroversies related to treatment of breast cancer have always been intense, but conflicting research findings on treatment modalities and divergent theories of cancer spread leave women with breast cancer with more confusion than ever. This confusion, coupled with the fact that no treatment for breast cancer is benign, point to a crucial need for informed occupational health nurses to counsel women in the workplace. The purpose of this article is to explore the dilemmas faced by individuals with breast cancer and to discuss the potential roles of nurses in fostering adaptation during each transition in the cancer experience.
CURRENT DILEMMAS "I found a lump; now what?"
The nurse is often in a position to assist individuals to appraise the significance of a physical finding. With respect to a lump in the breast, all findings can be considered significant until necessary evaluation is completed. The person can be assured that approximately 90% of all breast lumps are benign, but the urgency of a definitive diagnosis must be stressed.
• Meaning of cancer and cancer treatment to the individual
The first step in facilitating a diagnostic workup is to ascertain the meaning of cancer to that individual. Delay between discovery of a lump and seeking treatment often is attributed to fear of disfiguring treat-For the female, the breast personifies femininity and nurturance, but the relative importance of these values varies with the individual. ment, Until recently, breast cancer therapy was based upon the proposition that breast cancer spreads locally by the lymphatics, and then systemically. The Halsted radical mastectomy, originally performed in 1902, was based on this theory. A radical mastectomy consists of removal of the entire breast, pectoralis major, pectoralis minor, and adjacent lymph nodes, resulting in disfigurement, which may serve to deter some women from seeking treatment. Current conservative therapy which includes the modified radical mastectomy or the lumpectomy and radiation, is based upon the assumption that metastases develop concurrently with local tumor development. The radical mastectomy now is the treatment of choice primarily in women who have a tumor fixed to muscles of the chest wall (McKhann, 1985) . Knowledge of the use of more conservative treatment options may make the difference in the decision to seek treatment.
• Meaning of the breast to the individual
For women who must lose breast tissue, counseling is dependent upon the meaning of the breast to that individual. For the female, the breast personifies femininity and nurturance, but the relative importance of these values varies with the individual. When the life-saving potential of the recommended therapy is explored and client decisions regarding treatment respected, therapy is more likely to be viewed positively.
A discussion of the excellent cosmetic results of current breast reconstruction procedures may allay fear of loss of the breast. The use of pictures (such as illustrated by Hartrampf, 1987) or slides illustrating reconstruction procedures and outcomes is a very convincing technique.
• Fear of loss of control
A second deterrent to seeking treatment is the fear of loss of control experienced by women undergoing a one-stage biopsy and treatment procedure (McKhann, 1985) . Some states now require a review of options. including a separate biopsy and surgical procedure. With the two-stage procedure, treatment decisions based on biopsy results are made jointly by the client and physician.
"How do I know what treatment is best?"
The popular press, the NCI infor-marion number (l-800-4-CANCER), and second opinions are means available to clients to acquire more information. The crucial points to note are that there may be no one best treatment and that comparing oneself to other individuals with breast cancer may not be appropriate. This question can be answered by considering characteristics of the tumor, and physician and client preferences. Questions regarding the tumor include invasiveness, extent of spread (stage), histology, differentiation (grade), and hormone receptor status.
• Characteristics of the tumor
Inoasioeness. Preinvasive or in situ carcinoma of the breast can be detected by mammography. In situ carcinoma may be either lobular or ductal. Lobular carcinoma in situ (LeIS) occurs in younger women, is often an incidental finding, has a tendencv toward b ila te ral itv and . . multiple foci, and has a reported invasiveness range of 0 to 38% (Lippmann, 1988) . Dilemmas faced by women with LCIS are the decision to have no further treatment, a simple mastectomy with or without a low axillary dissection, or bilateral mastectomy. A positive family history or extreme anxiety about invasive disease may be indications for more extensive treatment, but the decision to have surgery for a condition that mayor may not become invasive is an uncertainty that is difficult to resolve. In contrast, ductal carcinoma in situ (DCIS) is generally accepted to be a malignant process that will become invasive and metastasize if left untreated (Ozzello, 1983) . This malignancy occurs in the older age group, and has a tendency toward bilaterality and multiple foci. Treatment choices still range from wide excision with or without radiation to simple mastectomy with low axillary dissection (Lippmann, 1988) . A randomized clinical trial was initiated in 1985 to determine the optimal treatment choice for DCIS (Fisher, 1986a, b) , but until these data are available the uncertainty of treatment remains a dilemma to be resolved by each client and physician.
Staging. As with the in situ cancers, treatment options for invasive breast cancer range from wide excision with radiation to radical mastectomy. Invasion of breast cancer is staged according to tumor size, fixation to the muscles and fascia, the number and location of involved lymph nodes, and the presence or absence of distant metastases (Keys, 1983) . For example, Stage 0 indicates carcinoma in situ. Stage I refers to a malignancy 2 centimeters or less in size, with no nodal or distant metastasis, while Stage IV disease refers to a tumor of any size with extension to the chest wall or skin, positive nodes, and distant metastasis.
Histology. Histology is a less reliable indicator of prognosis than stage of invasive malignancies, but is a factor nevertheless. Infiltrating duct carcinoma is the most common type of breast cancer, comprising 70% of all invasive malignancies. Lobular carcinoma accounts for 5 to 10% of invasive breast cancers. Unfortunately, both of these types are associated with the poorest prognoses of the various tumor types. Histological types of invasive mammary cancer, which are generally associated with better prognoses, but which comprise only 10% of all cases, are medullary, tubular, mucinous or colloid, and infiltrating papillary carcinoma (Harris, 1985) .
Grade (differentiation). The grade, or degree of differentiation, also is a prognostic indicator in breast cancer. Mammary carcinomas have been categorized into grades of malignancy, depending on the degree of likeness to the tissue of origin. Tumors of low malignancy are categorized as Grade 1 (well differentiated) and comprise only 2 to 3% of breast tumors. The mosr malignant tumors (Grade 4) are poorly differentiated and comprise 70% of breast tumors (Harris, 1985) .
Hormone Receptor Status. Another tumor characteristic that is an important determinant of treatment is the hormone (estrogen and progesterone) receptor status. Hormone receptor status of the tumor is determined by a tissue sample taken during the biopsy. Estrogen receptors are The modified radical mastectomy is the most commonly used treatment for all stages of breast cancer.
found in 60% of women under 50 and 75% of women over 50 (Harris, 1985) . Women with hormone receptor negative tumors tend to have a higher recurrence rate and a lower response rate to hormonal therapy if metastases develop, than do women with hormone receptor positive tumors (Keys, 1983) . In the past, hormonal manipulation was accomplished by ablative therapy (ie , oopherectomy, transphenoidyl hypophysectomy, or bilateral adrenalectomy). Currently, less extreme methods of hormonal manipulation are employed, and an antiestrogen (Tamoxifen) is used instead.
• Physician preferences
The type of treatment a client receives for breast cancer may depend on the preferences of the physician. Even if several opinions are sought, regional and international differences frequently influence therapy. Physicians are faced with a rapidly changing field and unresolved controversies regarding treatment.
The modified radical mastectomy is the most commonly used treatment for all stages of breast cancer. The advantage of this procedure is the sparing of the pectoralis major and minor muscles and associated nerves which results in less deformity than a radical mastectomy (Powell, 1987) . However, recent clinical trials with Stages I and II disease indicate that with proper selection, lumpectomy or segmentectomy with axillary dissection and radiation therapy is a valid treatment option.
Some surgeons still consider breast conserving procedures to be controversial (Fisher, 1986b; Veronesi, Lying down:
To examine your right breast, put a pillow or folded towel under your right shoulder. Place righthand behind your head-this distributes breast tissue more evenly on the chest. With left hand, fingers flat, press gently in small circular motions around an imaginary clock face. Begin at outermost top of your right breast for 120'clock, then move to 1 0' clock, and so on around the circle back to 12. A ridge of firm tissue in the lower curve of each breast is normal. Then move in an inch, toward the nipple, keep circling to examine every part of your breast, including nipple. This requires at least three more circles. Now slowly repeat procedure on your left breast with a pillow under your left shoulder and left hand~:~~:~~~~~~t ices tructure feels.
Finally, squeeze theñ ipple of each breast gently between thumb and index finger. Any discharge, clear or bloody, should be reported to your doctor immediately.
WHAT YOU SHOULD DO IF YOU FIND A LUMP OR THICKENING
If a lump or dimple or discharge is discovered during BSE, it is important to see your doctor as soon as possible. Don't be frightened. Most breast lumps or changes are not cancer, but or.ly your doctor can make the diagnosis.
Before a mirror:
Inspect your breasts with arms at your sides. Next. raise your arms high overhead. Look for any changes in contour of each breast. L----L_U--_---' a swelling. dimpling of skin or changes in the nipple.
Then. rest palms on hips and press down r---==-----, firmly to flex your chest muscles. Left and right breast willnot exactly match-few women's breasts do.
Regular inspection shows what is normal for you and willgive you confidence in your examination.
Examine your breasts during bath or shower; hands glide easier over wet skin. Fingers flat. move gently over every part of each breast. Use right hand to examine left breast. left hand for right breast. Check for any lump. hard knot or thickening.
Most breast cancers are first discovered by women themselves. Since breast cancers found early and treated promptly have excellent chances for cure, learning how to examine your breasts properly can help save your life. Use the simple 3-step breast selfexamination (BSE) procedure shown here.
In the shower:
How to examine yourbreasts AMERICAN CANCER .SOCIElY· 1986). These concerns are based on the paucity of data on long-term survival differences and possible adverse . effects from radiation 10-30 years later (Powell, 1987) . Recently the National Cancer Institute (NCI) has sought to minimize differences in treatment protocols. A consensus conference was held bv the NCI in 1985 to resolve issues regarding the administration of adjuvant chemotherapy. Adjuvant therapy is used as a curative approach to kill cancer cells that are not c1inicallv detectable. Recommendations de~ived were the administration of Cvtoxan , Methotrexate, and 5-Fluo;ouracil (CMF) for 6 months to premenopausal women with positive lymph nodes and two years ofTamoxifen for postmenopausal women with positive estrogen receptors (NCI, 1985) .
Until recentlv, women without lymph node inv~lvement were considered to be at low risk for recurrent disease. Recent findings, however, that one-third of "node-negative" clients do have recurrence, led to a Phy-sician Alert by the NCI in May, 1988. The alert advises the consideration of adjuvant chemo or hormonal therapy for all women with early stage or "node-negative" breast cancer. Data from 3 recent unpublished studies demonstrated that adjuvant systemic chemotherapy and/or hormonal therapy resulted in statistically significant improvement in disease-free survival for women with early stage breast cancer (NCI Alert; May, 1988).
• Client variables
While characteristics of the tumor and physician preferences play major roles in determining treatment, factors related to the physiological and psychological makeup of the client are also important. Age, menopausal status, family history, personal preference, likelihood of compliance, education level, socioeconomic status, support of family and friends, and pre-existing health problems are factors that must be considered. For example, perons with little or no support, no means of transportation, and lower likelihood of compliance to treatment regimens may be better served by a modified radical mastectomy than by lumpectomy and radiation since the latter requires daily appointments for weeks of therapy.
"How can I deal with the effects of the diagnosis and treatment?" • Individual perceptions of loss
A woman newly diagnosed with breast cancer is confronted with a series of crises associated both with the diagnosis and treatment. Weisman (1976) identified the first 100 days after diagnosis as the most vulnerable period for dysfunctional responses to cancer, bu t research indicates that this period of vulnerability is extended for individuals with breast cancer (Brandt, 1985; Derogatis, 1979) . Individuals with a "fighting spirit" (Greer, 1979) , high expressiveness, and low social conflict (Spiegel, 1983), appear to have the fewest mood disturbances associated with diagnosis and treatment.
Two movements, individuals' involvement in health care and full disclosure of medical information, have resulted in the bombardment of the client with facts and decision-making demands at a time when anxiety and indecisiveness are high. The realization that no one "best" treatment of breast cancer is established, and that personal preference with respect to treatment will be considered, may result in extreme frustration.
Active listening and counseling assist individuals in dealing with uncertainty and resolving losses. Referrals to community resources may be warranted as welL
• Postoperative management
With the advent of the Prospective Payment System and Diagnostic Related Grouping (DRG), women with breast cancer, if admitted to the hospital, are being discharged earlier.
During the more lengthy hospitalizations of the past, staff nurses could teach women with mastectomies about the disease and treatment, and a Reach to Recovery volunteer could visit prior to discharge. Currently, with outpatient surgery and early discharge for those hospitalized, emotional support and essential teaching may be limited. Nurses in the workplace may encounter post-operative problems previously seen only by hospital nurses.
For example, surgical drains are almost always inserted after a mastectomy or lumpectomy with axillary node dissection. The drain is removed after the amount of drainage has diminished. Prior to discharge from the hospital or clinic, the client is instructed in drain care (emptying, measuring output, and recognizing and reporting signs of infection). However, clients with biopsies or lumpectomies may return to work before the drain is removed and the occupational health nurse can provide guidance in drain care and assist in determining the amount of work to be managed by the individual.
Generally the surgeon will require limitations to the range of motion (ROM) of the operative arm until the drain is removed. The client is taught basic exercises immediately postoperatively in order to maintain strength and range of motion (ROM) in the operative arm. After the drain is removed, the client can progress to more advanced exercises to maintain complete ROM and strength.
Further attention should be afforded women with axillary node dissections and/or radiation, because of the increased risk for lymphedema and infection of the operative arm. Although activity should be encouraged, precautions should be taken to prevent infections and edema.
These precautions include wearing protective garments such as gloves when engaged in activities at risk for trauma; avoiding injections, venipunctures, and blood pressure measurements in the operative arm; and avoiding tight, restrictive clothing. Prompt treatment and follow-up for trauma to the affected arm is also important.
• Phantom breast experience
Another phenomenon which may occur after a mastectomy is the sensation of a phantom breast. Twinges and itching are the most commonly reported symptoms (Nail, 1984) . Lierman (1988) suggested that nurses with long-term contact are in the best position to assist women with the phantom experience. Assuring women that the sensations are not uncommon and will usually go away is helpful.
• Radiation therapy
Regardless of the type of therapy used, radiation treatments can be associated with a number of symptoms that affect emotional and physical well-being. If interstitial implants are required, a hospital stay of 2 to 3 days is typical. Yet women usually receive external beam radiation as outpatients and frequently work during the treatment period. Radiation side effects may adversely affect work performance. External beam radiation to the breast is associated with skin reactions and fatigue (Wilson, 1982; Hassey, 1983) .
Fatigue is a common side effect and may last up to several months after treatment has ended (Hassey, 1985) . Women receiving radiation may need to alternate periods of work with rest and reduce work-related responsibilities during and after treatment. Time off from work also may have to be arranged for daily
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Active listening and counseling assist individuals in dealing with uncertainty and resolving losses.
treatmen ts. Skin reactions to radiation vary from person to person and may include itching, dryness, peeling, erythema, and hyperpigmentation. The occupational health nurse can follow the teachings of the radiation oncologist and nurse in reinforcing skin care guidelines.
• Chemotherapy
Adverse reactions to the antineoplastic drugs vary with the type of drug, the dose, and the overall health of the client. Adverse reactions may include nausea and vomiting, anorexia, skin changes (especially in previously irradiated areas), bone marrow suppression, renal and urinary tract problems, nervous system abnormalities, respiratory changes, reproductive and sexual dysfunctions, and psychological reactions (Nevidjon, 1984) .
While most adverse reactions are temporary, alterations in body functions may be serious enough to threaten life, as in bone marrow suppression. The occupational health nurse can support the employee by limiting work activities risky to compromised body systems, for example, avoiding exposure to workers with contagious diseases while the employee has a low white blood count.
Since women return to work on Tamoxifen, the occupational health nurse should know that the usual dosage of Tamoxifen is 10 mg PO BID, and minimal side effects are experienced. Nausea, vomiting, edema, hot flashes, vaginal dryness, and leukopenia are seen infrequently and are short term. Gastrointestinal symptoms, if experienced, are lessened after a few weeks and can be minimized by taking the drug with meals.
Within the first month of this or At no juncture in the treatment of breast cancer should clients be told that "nothing else can be done."
other endocrine therapy, clients may report alarming symptoms of increased musculoskeletal pain, erythema around the skin lesion, increased size of the skin lesion, or fever. The physician may find changes in liver enzymes, bone scans, or carcinoembryonic antigen (CEA) levels. This phenomenon is known as "flare." The clinical significance is not known, but the symptoms will subside. The client needs reassurance that the disease has not worsened markedly, and that generallv side effects are not an indication to discontinue therapy .
• Breast prostheses and reconstruction
The use of breast prostheses andl or reconstruction assists the client in adjusting to the changes caused by treatment. Many insurance companies cover either a prosthesis or reconstruction. Reconstruction is more costly; therefore, if reconstruction is a possibility, paying for a prosthesis to avoid losing insurance coverage for the reconstruction may be advised.
Many hospital oncology units provide lists of local breast prostheses suppliers. Suppliers also are listed under "prosthesis" in the Yellow Pages. Prostheses may be inflatable, weighted, or made of synthetic f1eshlike materials. Prices vary from the two-dollar cotton, stuffed prosthesis to the one-thousand dollar prosthesis by Image; which is made according to individual specifications. The client should shop for a quality fit and reasonable price before making a decision.
Advances in breast reconstruction have resulted in more women electing these procedures. The type of reconstruction that a plastic surgeon recommends depends on the original breast surgery. A submuscular silicone implant is the easiest and least painful operative procedure and can be used if the skin covering the anterior chest wall is adequately loose (Harris, 1985) . Flap procedures are available to women with inadequate skin coverage or large defects caused by removal of the pectoralis major. muscle. A flap is an area of partially detached tissue, typically including the skin, subcutaneous or rotated to an adjacent area.
The two most common flap procedures in breast reconstructive surgery are the rectus abdominus flap and the latissimus dorsi myocutaneous island flap. Both procedures are complicated and result in a longer hospitalization, increased pain, and longer recovery than the silicone implants (Bostwick, 1987) . For women in need of abdominoplasty, the rectus abdominus flap provides the added cosmetic effect of a "t u m m v tuck." Women who undergo a flap procedure are cautioned not to smoke because smoking can adversely affect the blood supply.
Breast reconstruction typically is conducted in two or more stages if the woman chooses nipple reconstruction. Nipples usually are reconstructed from the labia minora, inner thigh, post auricular area, or the opposite intact breast nipple (Bohmert, 1986) . Surgery of the uninvolved breast often is recommended to attain symmetry.
Oncologists and plastic surgeons tend to differ with respect to the optimal time for reconstruction. Simultaneous removal and reconstruction may be performed, but some surgeons prefer to wait at least 5 days post-mastectomy to ascertain the condition of the skin flaps and the stage of the disease. Other surgeons prefer to wait longer before performing the reconstruction to avoid masking local recurrence. "How do I live with the possibility of progression or recurrence?
Fear of recurrence is the primary uncertainty faced by the person with breast cancer. Recurrence is most common in the first two years after treatment, but the unique natural history of breast cancer is such that recurrence can occur as many as 25 to 30 years after diagnosis. Median survival after metastasis ranges from 11 to 24 months . Survival for over 15 years has been reported; therefore, women with metastatic breast disease are increasingly evident in the workplace.
• Detection and treatment of recurrence
The occupational health nurse should be informed of the most common sites of recurrence, symptomatology, and treatment (Table) .
Although attention to the most frequent sites is warranted, breast cancer has been known to metastasize to almost all organs of the body. Bone metastasis tends to carrv a better prognosis while multiple sites of metastasis and short disease-free intervals carry the worst prognoses . These differences are important to note in order to avoid the general tendency to associate metastasis with imminent death.
Attention to individual responses to symptomatology may be a significant contribution that the occupational health nurse can make. Persons who have cancer often attribute all symptomatology to the disease; therefore, the nurse needs to allay fears about commonly occurring illnesses, while staying attuned to indications of metastasis. Knowledge of the most common treatments and side effects will be constructive in helping the employee and coworkers to know what to expect. Isolated lesions, eg, brain or bone, are generally treated with radiation. Therapy may involve a four-week course; therefore, the client may return to work with fatigue or other symptoms requiring special work allowances or support.
• To treat or not to treat
Overall the prognosis with metastatic breast cancer is poor and treatment is palliative, but the client should be assured that symptomatic metastases can be treated and that survival varies. No evidence indicates that survival will be increased markedly by treating nonsymp- (Champ, 1978; Cohen, 1980; Fox, 1982; Goodwin, 1979; Marks, 1973) .
Ten years ago, Bonica identified cancer pain as a major national health problem (1978) . While progress has been made in pain management since 1978, countless people with cancer pain continue to suffer. Occupational health nurses can serve in the crucial role of client advocate by encouraging women to seek and demand adequate pain management. tornutic metastases; therefore, the nurse may be in the position of counseling clients who are not being treated for bony metastases in non weight-bearing joints, for example. The client may be quite uncomfortable with receiving no therapy for known disease, yet present research indicates that treatment should be reserved primarily for symptom control.
Another issue that clients may question is the ordering of expensive tests to detect metastasis. Follow-up and judicious tests are recommended, but most metastases are found when symptomatic. Since prognosis has not been found to change significantly with asymptomatic treatment , the client may need an advocate when testing seems exorbitant in costs or discomfort.
Finally, the unrelentless continuation of therapy needs to be avoided. At some point in therapy, the toxicity may outweigh the benefits. Helping the client, family, and physician to agree on this point may be a major contribution. To withhold therapy may be more humane than continuing to treat a nonresponsive disease process.
"What happens if treatment fails?"
At no juncture in the treatment of breast cancer should clients be told that "nothing else can be done." When curative therapy fails, palliative therapy is continued. Recent advances have been made in symptom control, and each client has the right to palliative treatment until death, or until new treatments are discovered. The two most frequently reported responses to death are the fears of dying in pain and dying alone.
• Managing Pain
Women with breast cancer have good reason to fear dying in pain. Breast cancer usually is not painful in the beginning, but as the disease progresses, several types of excruciating pain syndromes may develop. The means to alleviate the majority of acute and chronic pain syndromes exist, but the incidence of unrelieved Three key concepts listed by McCaffery (1989) are useful guides in managing both acute and chronic pain: 1) Use a preventive approach, 2) Titrate to maximize effect, and 3) Keep the client in control. While it is beyond the scope of this article to elaborate on these principles, medical and nursing literature are replete with articles and books devoted to cancer pain management.
Several analgesic alternatives do not cause sedation or impair the ability to work. One of the most underrated categories of analgesics is non-Discussion of death allows time to complete unfinished business, resolve conflicts, and plan for significant others.
steroidal anti-inflammatory drugs (NSAIDS). Tylenol, aspirin, ibuprofen, and naproxen are included in this category. Kantor (1984) stated that up to 50% of all cancer patients with pain can expect relief with NSAIDS alone. The combination of NSAIDS with narcotics can be extremely effective in alleviating moderate to severe pain but must be used with caution in the workplace due to the, sedative and mood alteration effects of the opiates. Adjuvant analgesics such as tricyclic antidepressants can be effective in low doses for certain types of pain such as dull aching or burning, or pain associated with sleepless nights and anxiety (McCaffery, 1989) .
• Dying alone
In the past 20-30 years, discussion of death has become less of a taboo topic among people with cancer. Discussion of death allows time to complete unfinished business, resolve conflicts, and plan with significant others. The rights of the individual to enter into, or avoid such discussions should be respected, and a team approach will enhance the effectiveness of professionals in assessing and meeting these individual needs. Kastenbaum (1976) contends that the typical response to the desire of a person to discuss death tends to be evasion. The five typical responses identified by thanatologists can serve as a guide to determine personal willingness to discuss death: 1) Reassurance ("You're doing so well"). 2) Denial ("Oh, you'll live to be a hundred"). 3) Changing the subject ("Let's talk abou t something more cheerful"). 4) Fatalism ("Well we all have to die sometime"). 5) Discussion ("What happened to make you feel that way?") (Kastenbaum, 1976) . Few professionals are comfortable choosing the latter strategy which gives the client permission to discuss death openly. Most people with cancer fear lingering, either naturally or because of the use of medical heroics. Appropriate timing of client, family, and professional consensus on "no codes" and the signing of Living Wills provide some reassurance with respect to these fears.
Dying at home with the family present is a goal for some that is not always attainable. Early referral to a home-care agency or hospice service is a primary means to assist in achieving this goal. Freestanding or institutional hospices are other services that may facilitate a peaceful death as well as support families through the dying and bereavement processes.
FUTURE TRENDS
Future treatments for breast cancer may include promising variations on old themes and exciting new ideas. Keeping up-to-date with a rapidly changing field will be a challenge to nurses in the position to counsel and to have a positive effect on the lives of millions of women with or at risk for breast cancer.
Preventive treatments may include the use of drugs such as Tamoxifen or gonadotropin releasing hormone antagonists in women at high risk for breast cancer, and the reduction of caloric intake in order to maintain low, lean body weight. New diagnostic tests for recurrent breast cancer may include the use of flow cytometry which measures the growth rate and amount of DNA contained by cancer cells, bone marrow tests, monoclonal antibodies, and oncogene markers (Bonadonna, 1988) .
New trends in the treatment of breast cancer may include the timing of breast cancer surgery to coincide with ovulation, which has been found to be associated with longer survival rates in mice, the timing of chemotherapy to coincide with the natural biorhythms of the body to enhance anticancer effects and minimize toxic effects (Chronobiology and drugs, 1988) , the use of computer programs to predict recurrence (Bullock, 1988) , the development of less toxic antineoplastic agents, more extensive use of chemotherapy or irradiation prior to surgery, and increasing dose intensities of antineoplastic drugs (Hyrniuk, 1984) .
SUMMARY
This article has outlined the major dilemmas experienced by the person with breast cancer and discussed information helpful for the occupational health nurse in assisting the client and family to cope with each. This approach is not intended to imply that all clients do not survive. The 5-year survival rate for in situ cancer (noninvasive) approaches 100%. The survival rate for localized cancer is 90%, but if the cancer has spread, the rate is 60% (American Cancer Society, 1988).
The occupational health nurse is in a strategic position to encourage prevention and surveillance, as well as to counsel employees during diagnosis, treatment, and rehabilitation. Those who fail to survive need individual and family support, but the occupational health nurse must be equally astute in helping survivors to achieve the same or higher quality of life as that experienced prior to diagnosis, and in some cases challenging the "cured" to assume volunteer roles to assist others.
